(Q41104561)

26 September 2017

title

Selection of a muramyl peptide based on its lack of activation of nuclear factor-kappa B as a potential adjuvant for AIDS vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1424273

25 September 2022

author name string

R. Schreck

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1424273

25 September 2022

D. Bevec

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1424273

25 September 2022

P. Dukor

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1424273

25 September 2022

P. A. Baeuerle

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1424273

25 September 2022

L. Chedid

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1424273

25 September 2022

G. M. Bahr

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1424273

25 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1424273

25 September 2022

publication date

1 November 1992

1 reference

Clinical and Experimental Immunology

26 September 2017

published in

1 reference

26 September 2017

volume

90

1 reference

26 September 2017

issue

2

1 reference

26 September 2017

page(s)

188-193

1 reference

SDZ MRL 953, a novel immunostimulatory monosaccharidic lipid A analog with an improved therapeutic window in experimental sepsis

26 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1992.TB07926.X

Effect of a synthetic adjuvant on the induction of primary immune responses in T cell-depleted spleen cultures

21 January 2018

1 reference

12 December 2020

Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptides

1 reference

12 December 2020

Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65

1 reference

12 December 2020

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

1 reference

12 December 2020

Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression

1 reference

12 December 2020

Enhancement of B-cell stimulation by muramyl dipeptide through a mechanism not involving interleukin 1 or increased Ca2+ mobilization or protein kinase C activation

1 reference

12 December 2020

Vaccine protection against simian immunodeficiency virus infection

1 reference

12 December 2020

Activation of HIV gene expression during monocyte differentiation by induction of NF-kB

1 reference

12 December 2020

An inducible transcription factor activates expression of human immunodeficiency virus in T cells

1 reference

12 December 2020

Future prospects for vaccine adjuvants.

1 reference

12 December 2020

Prospects for the control of AIDS by immunizing seropositive individuals

1 reference

12 December 2020

Enhanced superoxide anion release from phagocytes by muramyl dipeptide or lipopolysaccharide

1 reference

12 December 2020

Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells

1 reference

12 December 2020

Specific inhibition of mRNA accumulation for lymphokines in human T cell line Jurkat by mycobacterial lipoarabinomannan antigen

1 reference

12 December 2020

Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope protein

1 reference

12 December 2020

Modern vaccines. Human immunodeficiency virus and AIDS: challenges and progress

1 reference

12 December 2020

DNA binding of purified transcription factor NF-kappa B. Affinity, specificity, Zn2+ dependence, and differential half-site recognition

1 reference

12 December 2020

Tampering with transcription

1 reference

12 December 2020

Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1

1 reference

12 December 2020

1 reference

12 December 2020

Enhancement of non-specific resistance to viral infection by muramyldipeptide and its analogs

1 reference

12 December 2020

Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B

1 reference

12 December 2020

Effect of muramyl peptides and tumor necrosis factor on oxidative responses of human blood phagocytes

1 reference

12 December 2020

A formalin-inactivated whole SIV vaccine confers protection in macaques

1 reference

12 December 2020

The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine

1 reference

12 December 2020

Stimulation of non-specific resistance to infection by muroctasin

1 reference

12 December 2020

Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor

1 reference

12 December 2020

Immunological activities of muramyl peptides

1 reference

12 December 2020

Chemical structure and biological activity relationship of bacterial cell walls and muramyl peptides

1 reference

12 December 2020

Muramyl peptides. Variation of somnogenic activity with structure

1 reference

12 December 2020

Status of immune-based therapies in HIV infection and AIDS.

1 reference

12 December 2020

10.1111/J.1365-2249.1992.TB07926.X

Identifiers

DOI

1 reference

26 September 2017

0 references

1 reference